# LAP-ABLATE (NCT05585554)

> Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05585554
- Phase: NA
- Status: NOT_YET_RECRUITING
- Sponsor: Viewray Inc.
- Conditions: Pancreatic Cancer
- Interventions: MRIdian
- Enrollment: 267
- Primary outcome: Overall Survival (OS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 14
- Podcasts: 1
- X videos: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=lap-ablate-nct05585554

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05585554", "email": "<work email>"}; the inbox owner confirms by the emailed link.